Macro Group Pharmaceuticals - Macro Capital

EGX:MCRO Egypt
Market Cap
$245.21
EGP12.40K EGP
Market Cap Rank
#49482 Global
#216 in Egypt
Share Price
EGP1.36
Change (1 day)
+0.00%
52-Week Range
EGP0.84 - EGP3.88
All Time High
EGP4.51
About

Macro Group Pharmaceuticals - Macro Capital operates in various business sectors.

Market Cap & Net Worth: Macro Group Pharmaceuticals - Macro Capital (MCRO)

Macro Group Pharmaceuticals - Macro Capital (EGX:MCRO) has a market capitalization of $245.21 (EGP12.40K) as of March 19, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #49482 globally and #216 in its home market, demonstrating a -1.45% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Macro Group Pharmaceuticals - Macro Capital's stock price EGP1.36 by its total outstanding shares 9116 (9.12K).

Macro Group Pharmaceuticals - Macro Capital Market Cap History: 2022 to 2026

Macro Group Pharmaceuticals - Macro Capital's market capitalization history from 2022 to 2026. Data shows change from $591.38 to $245.21 (-25.35% CAGR).

Macro Group Pharmaceuticals - Macro Capital Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Macro Group Pharmaceuticals - Macro Capital's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:
  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of MCRO by Market Capitalization

Companies near Macro Group Pharmaceuticals - Macro Capital in the global market cap rankings as of March 19, 2026.

Key companies related to Macro Group Pharmaceuticals - Macro Capital by market ranking:

  • AZEV4F (SA:AZEV4F): Ranked #49473 globally with a market cap of $267.39 USD ( R$1.63K BRL).
  • Merit Packaging Ltd (KAR:MERIT): Ranked #49474 globally with a market cap of $267.30 USD ( PKRs74.53K PKR).
  • Sorted Group Holdings Plc (LSE:SORT): Ranked #49483 globally with a market cap of $264.92 USD ( GBX2.18 Million GBX).
  • Oilboy Energy L (KAR:OBOY): Ranked #49484 globally with a market cap of $264.89 USD ( PKRs73.86K PKR).

Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#49473 AZEV4F SA:AZEV4F $267.39 R$0.17
#49474 Merit Packaging Ltd KAR:MERIT $267.30 PKRs7.74
#49483 Sorted Group Holdings Plc LSE:SORT $264.92 GBX28.50
#49484 Oilboy Energy L KAR:OBOY $264.89 PKRs8.17

Macro Group Pharmaceuticals - Macro Capital Historical Marketcap From 2022 to 2026

Between 2022 and today, Macro Group Pharmaceuticals - Macro Capital's market cap moved from $591.38 to $ 245.21, with a yearly change of -25.35%.

Year Market Cap Change (%)
2026 EGP245.21 +19.30%
2025 EGP205.54 -50.86%
2024 EGP418.30 -21.36%
2023 EGP531.89 -10.06%
2022 EGP591.38 --

End of Day Market Cap According to Different Sources

On Mar 19th, 2026 the market cap of Macro Group Pharmaceuticals - Macro Capital was reported to be:

Source Market Cap
Yahoo Finance $245.21 USD
MoneyControl $245.21 USD
MarketWatch $245.21 USD
marketcap.company $245.21 USD
Reuters $245.21 USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.